Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

GSK

GSK Plc ADR

Jan 06 • 04:00PM ET

50.56

+1.54 3.14 %

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: PPH AVDE FENI FVD RODM DFAX AQEC BINV AVIV FFLC

Scroll to Statements

Index	-	P/E	14.42	EPS (ttm)	3.51	Insider Own	0.00%	Shs Outstand	2.02B	Perf Week	2.95%
Market Cap	101.98B	Forward P/E	10.36	EPS next Y	4.88	Insider Trans	-	Shs Float	2.02B	Perf Month	4.10%
Enterprise Value	120.90B	PEG	1.06	EPS next Q	0.63	Inst Own	19.28%	Short Float	0.56%	Perf Quarter	16.36%
Income	7.22B	P/S	2.42	EPS this Y	13.03%	Inst Trans	-0.27%	Short Ratio	2.56	Perf Half Y	31.39%
Sales	42.06B	P/B	4.68	EPS next Y	8.29%	ROA	9.00%	Short Interest	11.23M	Perf YTD	3.10%
Book/sh	10.80	P/C	22.91	EPS next 5Y	9.76%	ROE	35.62%	52W High	49.63 1.87%	Perf Year	48.92%
Cash/sh	2.21	P/FCF	12.75	EPS past 3/5Y	-24.61% -11.63%	ROIC	17.27%	52W Low	31.72 59.42%	Perf 3Y	43.92%
Dividend Est.	1.72 (3.41%)	EV/EBITDA	8.31	Sales past 3/5Y	5.68% -1.42%	Gross Margin	72.45%	Volatility	0.99% 1.15%	Perf 5Y	34.30%
Dividend TTM	1.69 (3.34%)	EV/Sales	2.87	EPS Y/Y TTM	128.66%	Oper. Margin	23.49%	ATR (14)	0.78	Perf 10Y	23.11%
Dividend Ex-Date	Nov 14, 2025	Quick Ratio	0.55	Sales Y/Y TTM	5.97%	Profit Margin	17.16%	RSI (14)	66.14	Recom	2.57
Dividend Gr. 3/5Y	-16.94% -9.13%	Current Ratio	0.84	EPS Q/Q	3676.49%	SMA20	3.44%	Beta	0.47	Target Price	48.53
Payout	94.89%	Debt/Eq	1.10	Sales Q/Q	10.64%	SMA50	5.90%	Rel Volume	1.35	Prev Close	49.02
Employees	68629	LT Debt/Eq	0.92	Earnings	Oct 29 BMO	SMA200	22.22%	Avg Volume	4.39M	Price	50.56
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.87% 2.56%	Trades		Volume	5,922,215	Change	3.14%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Barclays	Equal Weight → Underweight
Nov-25-25	Upgrade	BofA Securities	Underperform → Neutral
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform

Show Previous Ratings

Today 12:48PM	GSK Wins Japan Approval for Exdensur (GuruFocus.com)
11:12AM	MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine (Zacks)
Jan-05-26 02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
Dec-31-25 11:03AM	Pfizer and GSK Lead 2026 U.S. Drug Price Hikes (GuruFocus.com)
09:34AM	Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs (GuruFocus.com)
09:40AM	Loading…
Dec-30-25 09:40AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
Dec-29-25 11:59PM	Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? (Insider Monkey)
03:28AM	HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target (Insider Monkey)
Dec-24-25 10:33AM	Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know (Zacks)
Dec-22-25 08:27AM	Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals (Zacks)
Dec-19-25 04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
02:50PM	Nine Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
02:50PM	More Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
12:15PM	Loading…
12:15PM	Pharma's $370B Bet on America: The ETF Plays for 2026 (Zacks)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
08:12AM	Will GILD's Strong HIV Portfolio Reap Rewards in 2026? (Zacks)
Dec-18-25 10:41AM	Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026? (Zacks)
07:41AM	GSK Gains FDA Approval for Exdensur in Severe Eosinophilic Asthma (GuruFocus.com)
07:27AM	GSK's Asthma Drug Gets U.S. Greenlight--$4 Billion Blockbuster in the Making? (GuruFocus.com)
Dec-17-25 10:29AM	GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment (Zacks)
09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-16-25 09:55PM	Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma (Business Wire)
08:53AM	GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal (Zacks)
Dec-15-25 10:49AM	FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer (Zacks)
10:27AM	GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU (Zacks)
Dec-12-25 01:53PM	GSK's $4 Billion Asthma Drug Gets First-Ever Green Light in Europe (GuruFocus.com)
10:08AM	GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea (Zacks)
07:28AM	GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation (Insider Monkey)
03:00AM	Loading…
03:00AM	US is best place to invest, says boss of British drugs giant (The Telegraph)
Dec-11-25 11:03AM	GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer (Zacks)
09:12AM	GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell? (Zacks)
Dec-10-25 11:28AM	J.P. Morgan Maintains a Sell Rating on GSK plc (GSK) (Insider Monkey)
09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Dec-09-25 09:10AM	How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks (Zacks)
Dec-04-25 11:30AM	Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-25 09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Dec-02-25 09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Dec-01-25 04:21PM	Top Analyst Reports for Palantir, Philip Morris & TotalEnergies (Zacks)
Nov-25-25 07:22PM	U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs (The Wall Street Journal)
04:14AM	BofA upgrades Novartis and GSK as pivotal data, new launches approach (Investing.com)
Nov-21-25 04:46PM	AnaptysBio Reverses Higher After Trading Legal Barbs With Pharma Giant GSK (Investor's Business Daily)
02:37PM	Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. (Investor's Business Daily)
09:47AM	AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK (Investor's Business Daily)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
06:14AM	GSK, AnaptysBio Sue Each Other Over Cancer Drug License (The Wall Street Journal)
Nov-19-25 10:09PM	JPMorgan Lowers GSK Price Target, Maintains Underweight Rating (Insider Monkey)
Nov-18-25 10:33AM	Alector Stock Plummets 63% in a Month: Here's What You Need to Know (Zacks)
Nov-17-25 09:50AM	GSK (GSK) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Nov-14-25 08:11AM	GILD's Investigational Regimen for HIV Treatment Meets Primary Goal (Zacks)
06:50AM	The Best Healthcare Stock to Hold in Uncertain Times (Motley Fool)
Nov-13-25 09:45AM	Why GSK (GSK) is a Top Growth Stock for the Long-Term (Zacks)
Nov-11-25 09:55PM	Deutsche Bank Maintains a Hold Rating on GSK plc (GSK) (Insider Monkey)
Nov-06-25 11:58AM	Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans (Zacks)
11:16AM	Modernas Quarter Wasnt As Bad as It Could Have Been. The Stock Is Up. (Barrons.com)
07:29AM	Moderna Swings to a Loss. The Stock Jumps Anyway. (Barrons.com)
Nov-05-25 04:15PM	Moderna Is Running Low on Cash. Its Earnings Are Thursday. (Barrons.com)
01:54PM	Eli Lilly Stock Sees RS Rating Rise To 77 (Investor's Business Daily)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-04-25 08:09PM	GSK PLC (GSK) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Upgraded Guidance (GuruFocus.com)
08:38AM	HIV, Livdelzi Fuel GILD's Q3 Top Line Amid Cell Therapy Sales Decline (Zacks)
08:36AM	Should You Buy Moderna Stock Ahead of Q3 Earnings Report? (Zacks)
Oct-31-25 10:20AM	GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow (Zacks)
Oct-30-25 10:34AM	Analyst Report: GSK plc (Morningstar Research)
07:45AM	GSK Rises 7% After Raising 2025 Profit Forecast (GuruFocus.com)
Oct-29-25 09:32PM	Jefferies Bullish on GSK, Citing Growth Pipeline and Efficiency Prospects (Insider Monkey) +5.10%
04:12PM	GSK Jumps On Hiked 2025 Outlook, But CEO Remains 'Very Cautious' About Vaccines (Investor's Business Daily)
02:34PM	GSK Stock Surges as CEO Exits on a High Note with Forecast Hike and Surprise Drug Win (GuruFocus.com)
02:31PM	GSK Lifts 2025 Outlook on Strong HIV and Cancer Drug Growth (GuruFocus.com)
11:48AM	GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View (Zacks)
08:58AM	GSK Jumps After Hiked 2025 Guidance Widely Outperforms Expectations (Investor's Business Daily)
08:58AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings? (Zacks)
07:24AM	GSK Lifts Guidance After Specialty Medicines Boost Sales (The Wall Street Journal)
07:05AM	GSK (GSK) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:08AM	GSK Raises Guidance After Sales, Earnings Growth (The Wall Street Journal)
Oct-28-25 09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Oct-24-25 04:12PM	GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short (Investor's Business Daily) -5.05%
12:07PM	A GSK Cancer Drug Is Making a Comeback. It's So-So News for the Stock. (Barrons.com)
Oct-23-25 08:11PM	Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma (Business Wire)
10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-22-25 06:45PM	Top Analyst Reports for Oracle, Toyota & Morgan Stanley (Zacks)
10:00AM	GSK (GSK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-21-25 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Oct-20-25 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
09:30AM	Will Positive Regulatory Updates Further Boost INCY Stock? (Zacks)
Oct-14-25 10:56AM	Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? (Zacks)
Oct-10-25 08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Oct-09-25 09:45AM	Why GSK (GSK) is a Top Growth Stock for the Long-Term (Zacks)
Oct-07-25 09:37AM	Gilead Resolves Patent Litigations for HIV Treatment Biktarvy (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-03-25 12:10PM	Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-02-25 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Oct-01-25 05:34PM	GSK (GSK) Touches All-Time High on Potential Exemption From Trump Tariff (Insider Monkey) +5.44%
04:36PM	Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff (Investor's Business Daily)
12:37PM	GSK's $30B US Gamble Sends Pharma Stocks Soaring After Trump Pricing Deal (GuruFocus.com)
10:00AM	New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level (Business Wire)
Sep-30-25 07:48PM	Analyst Report: GSK plc (Morningstar Research) +5.01%
Sep-29-25 04:25PM	GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley (Investor's Business Daily)
11:18AM	GSK Will Replace CEO Walmsley With a Company Insider. The Stock Is Up. (Barrons.com)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience